PHUONG-THAO CHOUNLAMANY: Open Payments
NPI 1871877209 · DESOTO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,413 in 75 payments from 16 companies in 2025. Trend: 2023 $637 · 2024 $1,154 · 2025 $1,413
Food & beverage: $1,413
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 37 | $564 |
| Janssen Biotech, Inc. | 11 | $213 |
| Astellas Pharma US Inc | 8 | $174 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $100 |
| IMMUNITYBIO, INC. | 2 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| COLOPLAST CORP | 1 | $33 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $23 |
| UROGEN PHARMA, INC. | 1 | $23 |
Products named: GEMTESA, ORGOVYX, ERLEADA, Xtandi, Nubeqa, ANKTIVA, PLUVICTO, KEYTRUDA.
Industry payments across TX — which companies pay providers there.
